ÐÂÎÅ×ÊѶ
ÒªÎÅ¿ìѶ | ÉϺ£µÚ¾ÅÈËÃñÒ½Ôº·¢²¼¸¨ÖúÉúÖ³Ñо¿ÖØÒª³É¹û
- ·ÖÀࣺ»ªÓ¯ÊÓ½Ç
- ×÷ÕߣºÐ¡¸ß
- À´Ô´£ºk8¿·¢(Öйú)¹«ÖÚºÅ
¡¾¸ÅÒªÃèÊö¡¿»ÆÌåͪӰÏìÂÑĸϸ°û²úÁ¿µÄ»úÖÆ
ÒªÎÅ¿ìѶ | ÉϺ£µÚ¾ÅÈËÃñÒ½Ôº·¢²¼¸¨ÖúÉúÖ³Ñо¿ÖØÒª³É¹û
¡¾¸ÅÒªÃèÊö¡¿»ÆÌåͪӰÏìÂÑĸϸ°û²úÁ¿µÄ»úÖÆ
- ·ÖÀࣺ»ªÓ¯ÊÓ½Ç
- ×÷ÕߣºÐ¡¸ß
- À´Ô´£ºk8¿·¢(Öйú)¹«ÖÚºÅ
- ·¢²¼Ê±¼ä£º2022-01-20 17:36
- ·ÃÎÊÁ¿£º
ÔÚ¸¨ÖúÉúÖ³ÁìÓò£¬Ôм¤ËØ£¨progestin£©×÷ΪһÖÖÓÐЧµÄ¹ýÔçÅÅÂÑÒÖÖƼÁ£¬ÒѾ±»ÓÃ×÷ÖÎÁƲ»ÔÐÖ¢µÄÐÂÐÍÂѳ²´Ì¼¤·½°¸¡£È»¶ø£¬Ôм¤ËضÔÂѳ²µÄ¾Ö²¿×÷Óü°Æä¶ÔÁÙ´²½á¹ûµÄÓ°ÏìÉв»Çå³þ¡£
2021Äê1Ô£¬ÉϺ£½»Í¨´óѧҽѧԺ¸½ÊôµÚ¾ÅÈËÃñÒ½Ôº¿ïÑÓƽÑо¿ÍŶÓÔÚJ Adv Res£¨IF=10.479£©·¢±íÁËÌâΪ“Progesterone affects clinic oocyte yields by coordinating with follicle stimulating hormone via PI3K/AKT and MAPK pathways”µÄÑо¿³É¹û1£¬½ÒʾÁËÔм¤ËØ»ÆÌåͪӰÏìÁÙ´²ÂÑĸϸ°û²úÁ¿µÄDZÔÚ»úÖÆ¡£
ΪÁËÑо¿»ÆÌåͪ£¨progesterone£©¼°»ÆÌåͪºÍÂÑÅݴ̼¤ËØ£¨follicle-stimulating hormone£¬FSH£©ÈçºÎ¹²Í¬Ó°ÏìÂÑÅÝÉú³¤ºÍÂÑĸϸ°û²úÁ¿µÄ»úÖÆ¡£Ñо¿ÈËÔ±·ÖÎöÁ˾¹ýÂѳ²´Ì¼¤ºóµÄÌåÍâÊܾ«»¼ÕßµÄÁÙ´²½á¹û£¬½áºÏСÊóÂѳ²´Ì¼¤Ä£ÐͺÍÂÑÅÝÅàÑøϵͳÆÀ¹ÀÁË»ÆÌåͪ¶ÔÂÑĸϸ°û²úÁ¿¡¢ÂÑÅÝ·¢Óý¡¢¿ÅÁ£Ï¸°ûÔöÖ³ºÍ¼¤ËØ·ÖÃÚµÄÓ°Ïì¡£½á¹û·¢ÏÖ»ÆÌåͪ½µµÍÁËÂÑĸϸ°û²úÁ¿£¬¶øÔö¼ÓFSH¿ÉÍì¾ÈÂÑĸϸ°û²úÁ¿£¨Í¼1A£©¡£»ÆÌåͪÒÖÖÆСÊó¿ÅÁ£Ï¸°ûÔöÖ³²¢½µµÍÂÑÅÝÉú³¤Ëٶȣ¨Í¼1B£©£¬¼õÉÙÂÑĸϸ°ûÊýÁ¿£¨Í¼1C£©£¬¶øFSH¿ÉÍì¾È»ÆÌåͪÓÕµ¼µÄÂÑÅÝÉú³¤ºÍ¿ÅÁ£Ï¸°ûÔöÖ³µÄÒÖÖÆ×÷Óã¨Í¼1D£©¡£
ͼ1.»ÆÌåͪͨÓëÂÑÅݴ̼¤ËØÞ׿¹Ó°ÏìÂÑĸϸ°û²úÁ¿
½øÒ»²½Í¨¹ýÁ×Ëữ¿¹ÌåоƬ£¨Á×Ëữ¿¹ÌåоƬ·þÎñÓÉk8¿·¢(Öйú)Ìṩ£©Ñо¿ÈËÔ±·¢ÏÖPI3K/AKTºÍMAPKͨ·Ϊ´Ë¹ý³ÌÖеĹؼüÐźÅͨ·£¨Í¼2A£©£¬²¢Í¨¹ýWBʵÑé֤ʵÁË»ÆÌåͪÄܹ»½µµÍAKT¡¢ERKµÄÁ×Ëữˮƽ£¬¶øÌí¼ÓFSHºóÄܹ»Íì¾È»ÆÌåͪËùµ¼ÖµÄAKT¡¢ERKÁ×ËữˮƽµÄ½µµÍ£¬´Ó¶ø´Ù½øPI3K/AKTºÍMAPKÐźÅͨ·¼¤»î£¨Í¼2B£©¡£
ͼ2.»ÆÌåͪÓëÂÑÅݴ̼¤ËØͨ¹ýPI3K/AKTºÍMAPKͨ·Þ׿¹Ó°ÏìÂÑĸϸ°û²úÁ¿
×ÛÉÏ£¬¸ÃÑо¿·¢ÏÖÁ˸¨ÖúÉúÖ³³£ÓÃÒ©Îï»ÆÌåͪÄܹ»ÔÚÂѳ²´Ì¼¤¹ý³ÌÖÐÒÖÖÆÂÑÅÝÉú³¤ºÍÂÑĸϸ°ûÊýÁ¿£¬ÂÑÅݴ̼¤ËØ£¨FSH£©¿Éͨ¹ý»Øµ÷PI3K/AKTºÍMAPKÐźÅͨ·µÄ»îÐÔ£¬½ø¶øÞ׿¹»ÆÌåͪ¶ÔÓÚÂѳ²µÄÒÖÖÆ×÷Óã¨Í¼3£©¡£±¾Ñо¿µÄÏà¹Ø³É¹û¶ÔÓÚÈ˹¤ÉúÖ³ÁìÓòµÄÂѳ²´Ì¼¤·½°¸µÄ¸öÌ廯ÓÃÒ©¾ßÓÐÖØÒªÒâÒå¡£
ͼ3.»ÆÌåͪÓëÂÑÅݴ̼¤ËØÞ׿¹Ó°ÏìÂÑĸϸ°û²úÁ¿µÄ»úÀíģʽͼ
| ×ܽáÓë½áÂÛ
Ôм¤ËØ´ÙÅÅÂѴ̼¤(PPOS) ×÷ΪһÖÖÂѳ²´Ì¼¤·½°¸£¬ÔÚ¹ýȥʮÄêÖÐÒ»Ö±ÓÃÓÚ²»ÔÐÖ¢µÄÖÎÁÆ£¬ÉîÈëÀí½âÆä×÷ÓûúÖƶÔÓÚÍØÕ¹ÆäÓ¦ÓÃÖÁ¹ØÖØÒª¡£±¾Ñо¿Ê×ÏÈ·¢ÏÖÁË»ÆÌåͪÔÚÂѳ²´Ì¼¤¹ý³ÌÖÐÒÖÖÆ¿ÅÁ£Ï¸°ûÔöÖ³ºÍÂÑÅÝÉú³¤£¬¼õÉÙÂÑĸϸ°ûÉú²ú£¬²¢·¢ÏÖÂÑÅݴ̼¤ËØÄܹ»»Øµ÷»ÆÌåͪµÄ×÷Óã¬Ëæºóͨ¹ýÁ×Ëữ¿¹ÌåоƬ¼¼ÊõÕÒµ½Á˺ËÐĵ÷¿Øͨ·£¬Ñо¿¼ÓÉîÁËÎÒÃǶԻÆÌåͪ´ÙÅÅÂÑÆÚ¼äÂѳ²¶Ô´ÙÐÔÏÙ¼¤ËØ·´Ó¦µÄÈÏʶ¡£¸ÃÑо¿²»½ö½ô¿ÛÉç»áÏÖÏó£¬Îª½â¾öÁÙ´²ÎÊÌâÌṩÁËÔúʵµÄÀíÂÛ»ù´¡£¬Ò²ÎªÐźÅͨ·Ñо¿ÌṩÁ˾µä¿ÆÑÐÉè¼Æ·¶±¾¡£
| ²Î¿¼ÎÄÏ×
[1] Long H, Yu W, Yu S, et al. Progesterone affects clinic oocyte yields by coordinating with follicle stimulating hormone via PI3K/AKT and MAPK pathways[J]. Journal of Advanced Research, 2021(2).
µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã
µç»°£º400-869-2936£¬021-33968791
ÓÊÏ䣺support@wayenbiotech.com
´«Õ棺021-33938792
QQ£º2120485725
Õ½ÂÔºÏ×÷
Õ½ÂÔºÏ×÷
| Full Moon | RayBiotech | CDI | IZON | Bio-Rad | R&D Systems | IsoPlexis | ÄÏÄ£ÉúÎï | Å·Ò×ÉúÎï | ÆäÃ÷ÐÅÏ¢ | ÃÀ¼ªÉúÎï | ÂóÌØ»æÆ× |
Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿·¢(Öйú)Ô´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£